Living meta-analysis and evidence synthesis of therapies for COVID-19

click on circles to display study description...

ACEI-COVID (Bauer), 2021 NCT04353596

discontinuation of ACEI/ARB (n=104) vs. continuation of ACEI/ARB (n=100)

randomized controlled trial   some concerns about risk of bias

Studied treatment

discontinuation of RAS inhibition

Control treatment

continuation of RAS inhibition

Patients

COVID 19 outpatients

Method

open-label

35 centres in Austria and Germany

Remark